This month’s charity is The National Multiple Sclerosis Society, which mobilizes people and resources to drive research for a cure and to address the challenges of everyone affected by MS.

Because MS is a complex disease that is different for every individual, National MS Society takes a comprehensive and focused approach that can propel knowledge, better treatments, health care policies, and new disease management therapies forward, faster. The organization drives research and collaborates worldwide to stop MS in its tracks, restore lost function, and end the disease forever – for every single person with MS.

The National MS Society pursues all promising paths, while focusing on three priority areas:

  • Progressive MS
  • Nervous System Repair
  • Wellness and Lifestyle

The National MS Society drives progress through a comprehensive approach to research, including a variety of Society programs and funding mechanisms, such as Fast Forward which focuses on advancing the transition of promising new therapies to rapid commercial development and understanding mechanisms underlying the disease.

The Society supports and funds research activities spanning ALL research stages, including early discovery research, translational research that brings promising ideas forward into actual therapeutic solutions for testing, and clinical trials. They offer a spectrum of funding opportunities and other resources to develop and support MS investigators at virtually every stage of their careers.

The National MS Society is the best investment in driving solutions and changing the world for people with MS.  A few examples include:

  • Recruited more than 800 new MS researchers to the field.
  • Provided early career support and funding to nearly every thought leader in MS research.
  • Set standards in diagnosis, symptom management, pediatric MS, complementary and alternative medicine, rehabilitation research, clinical trial strategies and stem cell research.
  • Established the MS field of nerve and myelin repair which resulted in trials for treatment.
  • Drove research uncovering genes contributing to MS susceptibility and new treatment avenues.
  • Paved the way for all existing therapies – none of which existed 20 years ago

For more information visit